The invention provides a composition for inhibiting proline-directed protein kinase FA/glycogen synthase kinase 3α (PDPK FA/GSK-3α), experiments verified that the composition can effectively inhibit the PDPK FA/GSK-3α. In addition, inhibition of PDPK FA/GSK-3α can improve the clinical efficacy of cancer treatment and cure rate.